The mean age of the participants was 28 ± 9.93 years. Results of a study in chili showed that the mean age of MTF transsexual subjects was 31.88 years (
17). That study is consistent with the current study. Moreover, 43.75% of individuals had a university education. In a study, 43.7% of participants also had a diploma and academic degree (
15). According to present results, taking a Pap smear test was scarce among transgender individuals. A study found a lower prevalence of the Pap smear test in FTM compared to cisgender (non-transgender) individuals (
18). That study was in line with the current study. Female-to-male individuals are more likely to have an inadequate Pap test due to a combination of physical changes induced by testosterone therapy and FTM discomfort with the examination (
19). It seems that lack of knowledge, lack of access to health centers, lack of belief, self-stigma in transgender people, and discrimination by healthcare providers may be the reasons for this finding. As White Hughto and colleagues also reported, transgender people face suspiciously high rates of discernment, violence, and other forms of stigma (
20). However, this requires further studies.
In the present study, the majority of the MTF individuals did not undergo prostate cancer screening. Based on a report Nik-Ahd et al. between males to females, the prostate is retained even after gender-affirmation surgery, thereby needing continuing screening for prostate cancer (
21). Male-to-female transgender persons are at risk for prostate cancer. Transgender patients on hormone therapy for gender affirmation may be at risk for both over-grading of prostate cancer and are not recognized (
22).
The present results showed that the majority of the individuals did not undergo breast cancer screening. Based on a report by Clarke et al., there are risk factors for breast cancer increase, and a lot of data support breast cancer screening in transgender females and males (
23). A systematic study and meta-analysis determined that FTM and MTF individuals were at significantly higher risk of increasing breast cancer in comparison to cisgender males; however, they were at lower risk than cisgender females (
24).
The findings of this study indicate that less than 14 years old was the age of sexual debut for 30% of individuals. In a previous study, the youngest age of sexual debut was reported to be 12 years old (
25). Additionally, 70 % of individuals reported having more than one sexual partner during their life time. Among the participants, 73% FTM transsexual subjects had female sexual partners. while 23 MTF transsexual subjects had male sexual partners. Furthermore, 30% of individuals reported having casual or paying sexual partners. The results of Herbst et al.'s study were consistent with the findings of the present study. They showed that 31.7% of transgender females had multiple sex partners (
26). The study conducted revealed that 73% of the individuals had never used a condom. In this regard, a study found that MTF transsexual people had multiple partners, but FTM transsexual subjects often had steady sexual partners. Moreover, 47.6% of the subjects never used a condom (
27). In the present study, the majority of participants had never received HBV and HPV vaccines. Besides, 77% of them were never tested for HIV. Nematollahi et al.’s study is consistent with the present study. They revealed more than 72% of transgender persons never underwent HIV tests (
25). In Meites et al.’s study, 83% of the participants received at least one dose of HPV vaccine. They found that education level has been a strong predictor of receiving HPV vaccination (
28). Based on the findings of the study, genital warts were more prevalent in men that had sexual intercourse with other men or with transsexual women, 77% of whom had unprotected oral or anal sex in the past six months. Moreover, 52% of them received no information about HPV, or it was incomplete. They believed that condom use prevented HPV, and warts indicated HPV infection in a person. The high price of the HPV vaccine was reported as a barrier to vaccination (
29). According to the current study, it appears that insufficient information and limited access to free vaccination are likely key factors contributing to low HPV vaccine uptake.
In the present study, 73% of the individuals reported no symptoms indicating STIs throughout their lifetime. However, our findings are inconsistent with those of two other studies. Their results showed that the prevalence of STIs was between 13 and 21% in transgender females (
30,
31). Moreover, one participant suffered from HIV, and two people suffered from STIs, of whom 26% reported unprotected sex with casual partners and alcohol consumption before intercourse (
32). In this study, 34.4% of the participants had anal sex. Anal intercourse was the most high-risk sexual behavior according to 23% of the participants because sex acts were without a condom. Moreover, 94% had oral sex, and just 17% of them had vaginal sex, respectively. Study results were consistent with the present study; the majority of transgender participants are sexually active and prefer anal sex (
33). The results of a study showed that 57% of transsexual subjects had bisexual tendencies, and 30% of MTF transsexual subjects had sex with non-transsexual males in the past three months (
34). In the present study, 70% of the subjects believed that the chances of transmission are lower in anal sex than vaginal sex. A previous study was consonant with our findings, which found that 70% of transsexual subjects believed that a healthy person might appear to be HIV-positive. Therefore, they can be considered potential HIV transmission routes (
32).
The current study found that 37.5% of the participants reported experiencing sexual violence and harassment. These findings are congruent with the results of Johns et al.'s study. They showed that the prevalence of all experiences of violence and discrimination was higher among transgender persons, including 23.8% forced to have sexual intercourse and 26.4% physical violence (
35).
This is a cross-sectional survey in which causality cannot be concluded from the findings. It is necessary to carry out a qualitative study to find reasons for not referring to screening from deep layers of anecdotes and experiences of FTM and MTF. A strong point of this study was the research environment, which was the largest center for all transsexual people from the whole country. Moreover, the sample represented the transsexual population. However, this study had a limitation, including transsexual people who have not been referred to the clinic for their status so far.
5.1. Conclusions
High-risk behaviors are common in transsexual participants. It can be recommended that establishing specialized health centers are needed for transsexual subjects. Also, healthcare providers should offer services without stigma and discrimination. It may be prevented or reduce high-risk sexual behaviors and substance abuse outcomes.